Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • E-Pharmacy in trouble...

    E-Pharmacy in trouble for selling banned drugs

    Written by savita thakur thakur Published On 2017-01-23T16:57:16+05:30  |  Updated On 23 Jan 2017 4:57 PM IST
    E-Pharmacy in trouble for selling banned drugs


    BENGALURU: Myra Medicines, an E-pharmacy app seems to have landed itself in trouble after, the Drug Controller of Karnataka filed a case against the said company for selling of Schedule H drug and other banned medicines in the state without a valid prescription.



    The complaint against the venture was filed after an Non-government organisation (NGO) activist of Swadesh Seva Santha, Rahul Singh, who approached the Karnataka Drug Controller authority alleging that Myra Medicines was selling banned drugs as it is against the Drugs and Cosmetics Act 1940, Drugs and Cosmetics Rules 1945, the Narcotic Drugs and Psychotropic Substances Act, 1985 and FDA.



    As per all the regulations, any drug or medicine cannot be sold to the patient or any other person without a valid prescription signed by a registered medical practitioner.





    To prove the Myra Medicines's violations of the law, the member of the Swadesh Seva Santha NGO placed various ordered Corex, Schedule H medicines like Moxikind CV 625mg, Jalra M 50/500mg, Daonil 5mg and Nurokind 500 mcg through their app with the venture delivering all the medicines without demanding a valid prescription, reports
    TOI



    The activist issued a statement said, “Such practices of delivering banned and psychotropic medicines without a valid prescription can make a drug seem bio-available and safe, when in reality it is not. Long term use of banned drugs like Corex can lead to serious kidney damage or constipation. These banned and psychotropic drugs are being sold in bulk to the youth, which has resulted in high rise of drug abuse and antibiotic microbial resistance”.





    The Drugs and Cosmetics Act, 1940 is an Act of the Parliament of India which regulates the import, manufacture and distribution of drugs in India.The primary objective of the act is to ensure that the drugs and cosmetics sold in India are safe, effective and conform to state quality standards. The related Drugs and Cosmetics Rules, 1945 contains provisions for classification of drugs under given schedules and there are guidelines for the storage, sale, display and prescription of each schedule.






    banned drugse-pharmacyKarnataka Drug ControllerMyra MedicinesOnline PharmacyRahul SinghSwadesh Seva Santha
    Source : With inputs

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    savita thakur thakur
    savita thakur thakur
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok